Pfizer has said that initial lab studies suggest that a third dose of their Covid-19 vaccine may be needed to neutralise the new Omicron covid variant.
The study suggested that people who had received just two doses of the Pfizer/BioNTech vaccine had far fewer of the neutralising antibodies that fight the variant.
Boosting that with an additional third vaccine restored protection to similar levels provided against earlier strains of the virus.
Huw Edwards presents BBC News at Ten reporting by medical editor Fergus Walsh.
Please subscribe HERE http://bit.ly/1rbfUog
#BBCNews
You’re watching Path to the Presidency with the BBC’s Caitríona Perry and Sumi Somaskanda. In this episode, the duo are…
TORINO (ITALPRESS) – Paul Pogba non tornerà a vestire la maglia della Juventus: com’era nell’aria da alcune settimane, le parti…
ROMA (ITALPRESS) – “In quasi 10 anni è capitato più volte. Il presidente promulga leggi ed emana decreti e più…
EMPOLI (ITALPRESS) – Divertente amichevole e 2-2 finale fra Italia e Francia Under 21 al Castellani di Empoli. Azzurrini avanti…
The head of the largest organisation of public health professionals in the US says Donald Trump's pick for health secretary…